钆塞酸与钆贝葡胺联合增强肝脏MRI:参数优化研究
在14名健康志愿者中于3.0T行肝脏MRI,间隔20分钟先后注射钆塞酸(0.025或0.05 mmol/kg)与钆贝葡胺(0.1 mmol/kg),确定联合方案在自动检测钆贝葡胺团注后约60-120秒可获得均匀高信号的「纯白肝」;钆塞酸0.025 mmol/kg、翻转角25°-35°时肝/肌肉CNR最佳,且优于0.05 mmol/kg。作者认为该方案可行,但尚需未来研究证实能否提高肝转移瘤检出敏感度。
要点
- 联合方案在钆贝葡胺团注自动检测后约60-120秒成像,可获得均匀高信号的肝脏与血管。
- 钆塞酸0.025 mmol/kg联合钆贝葡胺0.1 mmol/kg时,翻转角25°-35°的肝/肌肉CNR最佳。
- 实现「纯白肝」的CNR表现,钆塞酸0.025 mmol/kg优于0.05 mmol/kg。
核心结论
- 钆塞酸与钆贝葡胺联合增强T1加权MRI可实现均匀的「纯白肝」,未来研究需证实该方案能否提高肝转移瘤患者的病灶检出敏感度。
研究设计与样本
- 在14名健康志愿者中于3.0T行肝脏MRI,两次访视均先注射钆塞酸(第1次访视0.025 mmol/kg,第2次访视0.05 mmol/kg),20分钟后注射钆贝葡胺(两次访视均为0.1 mmol/kg);实验1纳入8名受试者行多期屏气3D脂肪饱和T1加权扰相梯度回波成像以确定最佳成像窗口,实验2纳入6名受试者于三个不同翻转角行屏气3D脂肪饱和T1加权扰相梯度回波成像以确定最佳翻转角,评估信噪比与对比噪声比。
诊断标准与关键数值
- 联合方案在自动检测钆贝葡胺团注后约60-120秒,肝/肌肉CNR达最大并形成均匀高信号的肝脏与血管;钆塞酸0.025 mmol/kg时翻转角25°-35°可最小化肝/血管CNR并最大化肝/肌肉CNR;实现「纯白肝」的CNR表现,钆塞酸0.025 mmol/kg优于0.05 mmol/kg。
临床应用与阅片要点
- 作者认为联合钆塞酸与钆贝葡胺增强T1加权MRI实现均匀「纯白肝」是可行的;作者指出未来研究需证实该方案能否提高肝转移瘤患者的病灶检出敏感度。
局限性
- 研究在健康志愿者中进行,以肌肉作为转移灶的替代指标。
- 未来研究需证实该方案能否提高肝转移瘤患者的病灶检出敏感度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To demonstrate the feasibility of combined delayed-phase gadoxetic acid (GA) and gadobenate dimeglumine (GD) enhanced liver MRI for improved detection of liver metastases, and to optimize contrast agent dose, timing, and flip angle (FA).
METHODS: Fourteen healthy volunteers underwent liver MRI at 3.0T at two visits during which they received two consecutive injections: 1. GA (Visit 1 = 0.025 mmol/kg; Visit 2 = 0.05 mmol/kg) and 2. GD (both visits = 0.1 mmol/kg) 20 min after GA administration. Two sub-studies were performed: Experiment-1 Eight subjects underwent multi-phase breath-held 3D-fat-saturated T1-weighted spoiled gradient echo (SGRE) imaging to determine the optimal imaging window for the combined GA + GD protocol to create a homogeneously hyperintense liver and vasculature ("plain-white-liver") with maximum contrast to muscle which served as a surrogate for metastatic lesions in both experiments. Experiment-2 Six subjects underwent breath-held 3D-fat-saturated T1-weighted SGRE imaging at three different FA to determine the optimal FA for best image contrast. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were evaluated.
RESULTS: Experiment-1 The combined GA + GD protocol created a homogeneously hyperintense liver and vasculature with maximum CNR liver/muscle at approximately 60-120 s after automatic GD-bolus detection. Experiment-2 Flip angles between 25° and 35° at a dose of 0.025 mmol/kg GA provided the best combination that minimized liver/vasculature CNR, while maximizing liver/muscle CNR. CNR performance to achieve a "plain-white-liver" was superior with 0.025 mmol/kg GA compared to 0.05 mmol/kg.
CONCLUSION: Combined GA + GD enhanced T1-weighted MRI is feasible to achieve a homogeneously "plain-white-liver". Future studies need to confirm that this protocol can improve sensitivity of liver lesion detection in patients with metastatic liver disease.
引用
- Knobloch G, Colgan T, Wang X, et al. Combined gadoxetic acid and gadobenate dimeglumine enhanced liver MRI: a parameter optimization study. Abdom Radiol (NY). 2020. PMID: 31606763. doi:10.1007/s00261-019-02265-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。